Skip to main content
. 2015 May 18;126(3):291–299. doi: 10.1182/blood-2015-01-621664

Figure 2.

Figure 2

Overall survival in univariate analyses of patient subgroups. Patient subgroups were defined by baseline demographic and disease characteristics. The dotted line represents the overall unstratified HR for azacitidine vs CCR.